[Federal Register Volume 80, Number 18 (Wednesday, January 28, 2015)]
[Notices]
[Page 4593]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-01578]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration: Research Triangle 
Institute

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Research Triangle Institute applied to be registered as an 
importer of a certain basic class of narcotic controlled substance. The 
DEA grants Research Triangle Institute registration as an importer of 
this controlled substance.

SUPPLEMENTARY INFORMATION: By notice dated April 21, 2014, and 
published in the Federal Register on April 28, 2014, 79 FR 23373, 
Research Triangle Institute, Kenneth S. Rehder, Ph.D., Hermann 
Building, East Institute Drive, P.O. Box 12194, Research Triangle Park, 
North Carolina 27709, applied to be registered as an importer of a 
certain basic class of narcotic controlled substance. No comments or 
objections were submitted for this notice.
    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the 
registration of Research Triangle Institute to import the basic class 
of controlled substance is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated the company's 
maintenance of effective controls against diversion by inspecting and 
testing the company's physical security systems, verifying the 
company's compliance with state and local laws, and reviewing the 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above-named company is granted 
registration as an importer of noroxymorphone (9668), a basic class of 
narcotic controlled substance listed in schedule II.
    The company plans to import small quantities of the listed 
controlled substance for the National Institute on Drug Abuse for 
research activities.

    Dated: January 21, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-01578 Filed 1-27-15; 8:45 am]
BILLING CODE 4410-09-P